The CELLEX is comparable to the UVAR‐XTS for the treatment of acute and chronic graft versus host disease (GVHD)

Two extracorporeal photopheresis (ECP) instruments, the CELLEX and the UVARXTS are currently being used “off‐label” in the US for treatment of graft versus host disease (GVHD). Our study compared the performance of the two instruments in the setting of acute and chronic GVHD.

[1]  E. Spitznagel,et al.  The efficacy of extracorporeal photopheresis to arrest bronchiolitis obliterans in lung allograft recipients was compared between two automated photopheresis instruments , 2018, Transfusion.

[2]  P. Taylor,et al.  Comparison of the CELLEX™ and UVAR‐XTS™ closed‐system extracorporeal photopheresis devices in the treatment of chronic graft‐versus‐host disease , 2017, Journal of clinical apheresis.

[3]  E. Atilla,et al.  A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations , 2017, Balkan medical journal.

[4]  E. Wong,et al.  Extracorporeal photopheresis performed on the CELLEX® compared with the UVAR‐XTS® instrument is more efficient and better tolerated in children with steroid‐refractory graft‐versus‐host disease , 2015, Pediatric blood & cancer.

[5]  Ø. Bruserud,et al.  Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: immunological mechanisms and the results from clinical studies , 2014, Cancer Immunology, Immunotherapy.

[6]  C. Eby,et al.  Linear relationship between lymphocyte counts in peripheral blood and buffy coat collected during extracorporeal photopheresis , 2013, Transfusion.

[7]  M. Robin,et al.  Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[8]  L. Scudeller,et al.  Response and survival of patients with chronic graft‐versus‐host disease treated by extracorporeal photochemotherapy: a retrospective study according to classical and National Institutes of Health classifications , 2012, Transfusion.

[9]  B. Sandmaier,et al.  Defining the intensity of conditioning regimens: working definitions. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[10]  Heidi Chen,et al.  Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP). , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[11]  H. Einsele,et al.  Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time , 2005, Bone Marrow Transplantation.

[12]  F. Foss,et al.  Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors , 2005, Bone Marrow Transplantation.

[13]  J. Wagner,et al.  Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[14]  S. Piantadosi,et al.  Development of a prognostic model for grading chronic graft-versus-host disease. , 2001, Blood.

[15]  H. Greinix,et al.  Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study. , 2000, Blood.

[16]  R. Washko,et al.  Extracorporeal photochemotherapy does not suppress T- or B-cell responses to novel or recall antigens. , 1999, Journal of the American Academy of Dermatology.

[17]  B. Griffith,et al.  Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group. , 1998, The New England journal of medicine.